Medtronic Executives to Speak at Upcoming Investor Conferences

DUBLIN, Sept. 7, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences:

2021 Virtual Wells Fargo Healthcare Conference
Thursday, September 9, 2021, at 10:40 am EDT
Bob White, executive vice president & president, Medical Surgical Portfolio, will answer questions about the company.

Morgan Stanley 19^th Annual Global Healthcare Conference
Tuesday, September 14, 2021, at 10:15 am EDT
Geoff Martha, Medtronic chairman & chief executive officer, will answer questions about the company.

BofA Global Healthcare Conference 2021
Friday, September 17, 2021 at 12:35 pm EDT
Rob ten Hoedt, executive vice president & president, EMEA, will answer questions about the company.

A live webcast for each session will be available on the date and time of each of the conferences noted above by clicking on the Investors Events link at https://investorrelations.medtronic.com. An archived audio file will be available for replay on the same webpage later in the day.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-executives-to-speak-at-upcoming-investor-conferences-301369937.html

SOURCE Medtronic plc